Premium
Oligonucleotide‐mediated modulation of mammalian gene expression 1
Author(s) -
Scanlon Kevin J.,
Ohta Yukinori,
Ishida Hironori,
Kijima Hiroshi,
Ohkawa Tsukasa,
Kaminski Anna,
Tsai Jerry,
Horng George,
KashaniSabet Mohammed
Publication year - 1995
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.9.13.7557018
Subject(s) - ribozyme , oligonucleotide , gene , gene expression , biology , genetic enhancement , computational biology , sense (electronics) , rna , dna , regulation of gene expression , microbiology and biotechnology , genetics , chemistry
The notion that oligonucleotides can modulate gene‐specific expression was established more than a decade ago. Recent advances in molecu‐lar genetics have broadened the armamentarium used to manipulate gene expression in biological systems including triplex DNA, antisense RNA/DNA, and ribozymes (catalytic RNA). These oligonu‐cleotides demonstrated important early application to the elucidation of cellular signaling pathways. More recently, studies with these agents have probed their utility as potential therapeutic agents, especially in the realm of cancer. With the implementation of gene therapy in early clinical trials, oligonucleotide‐ mediated suppression of gene expression has emerged as an important strategy for gene therapy. This review will discuss the current knowledge in this field, focusing on the biology of triplex DNA, antisense oligonucleotides, and ribozymes.—Scanlon, K. J., Ohta, Y., Ishida, H., Kijima, H., Ohkawa, T., Kaminski, A., Tsai, J., Horng, G., Kashani‐Sabet, M. Oligonucleotide‐mediated modulation of mammalian gene expression. FASEB J. 9, 1288‐1296 (1995)